Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry L Klein

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitorJohn T Randolph, Xiaolin Zhang, Peggy P Huang, et al.
Journal of Medicinal Chemistry|September 9, 2011
P1-substituted symmetry-based human immunodeficiency virus protease inhibitors with potent antiviral activity against drug-resistant virusesDavid A Degoey, David J Grampovnik, Hui-Ju Chen, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitroLiangjun Lu, Tami J Pilot-Matias, Kent D Stewart, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742Tatyana Dekhtyar, Teresa I Ng, Liangjun Lu, et al.
Bioorganic & Medicinal Chemistry|July 11, 2006
Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIVWilliam J Flosi, David A DeGoey, David J Grampovnik, et al.
Plants (Basel, Switzerland)|January 8, 2023
Anti-Microbial Activity of Aliphatic Alcohols from Chinese Black Cardamom (Amomum tsao-ko) against Mycobacterium tuberculosis H37RvSo Young Lee, Gauri S Shetye, So-Ri Son, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitorsDale J Kempf, Jeffrey F Waring, David C Morfitt, et al.
European Journal of Medicinal Chemistry|June 6, 2017
QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activityMarcelo N Gomes, Rodolpho C Braga, Edyta M Grzelak, et al.
The Journal of Organic Chemistry|May 25, 2018
Residual Complexity Does Impact Organic Chemistry and Drug Discovery: The Case of Rufomyazine and RufomycinMary P Choules, Larry L Klein, David C Lankin, et al.
The Journal of Organic Chemistry|September 25, 2023
Unprecedented Benzoquinone Motifs Reveal Post-Oligomerizational Modification of ProanthocyanidinsShu-Xi Jing, Daneel Ferreira, Pankaj Pandey, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitorJohn T Randolph, Xiaolin Zhang, Peggy P Huang, et al.
Journal of Medicinal Chemistry|September 9, 2011
P1-substituted symmetry-based human immunodeficiency virus protease inhibitors with potent antiviral activity against drug-resistant virusesDavid A Degoey, David J Grampovnik, Hui-Ju Chen, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitroLiangjun Lu, Tami J Pilot-Matias, Kent D Stewart, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742Tatyana Dekhtyar, Teresa I Ng, Liangjun Lu, et al.
Bioorganic & Medicinal Chemistry|July 11, 2006
Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIVWilliam J Flosi, David A DeGoey, David J Grampovnik, et al.
Plants (Basel, Switzerland)|January 8, 2023
Anti-Microbial Activity of Aliphatic Alcohols from Chinese Black Cardamom (Amomum tsao-ko) against Mycobacterium tuberculosis H37RvSo Young Lee, Gauri S Shetye, So-Ri Son, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitorsDale J Kempf, Jeffrey F Waring, David C Morfitt, et al.
European Journal of Medicinal Chemistry|June 6, 2017
QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activityMarcelo N Gomes, Rodolpho C Braga, Edyta M Grzelak, et al.
The Journal of Organic Chemistry|May 25, 2018
Residual Complexity Does Impact Organic Chemistry and Drug Discovery: The Case of Rufomyazine and RufomycinMary P Choules, Larry L Klein, David C Lankin, et al.
The Journal of Organic Chemistry|September 25, 2023
Unprecedented Benzoquinone Motifs Reveal Post-Oligomerizational Modification of ProanthocyanidinsShu-Xi Jing, Daneel Ferreira, Pankaj Pandey, et al.
Pageof 4